Literature DB >> 19453852

Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix metalloproteinase-2 and matrix metalloproteinase-9 in experimental periodontitis.

M R Marques1, M C L G dos Santos, A F da Silva, F H Nociti, S P Barros.   

Abstract

BACKGROUND AND
OBJECTIVE: Intermittent administration of the parathyroid hormone (1-34) has an anabolic effect on bone and it has been shown to reduce alveolar bone loss in experimental periodontitis models. The aim of the present study was to investigate the effect of parathyroid hormone on tissue degradation-related factors in an experimental periodontitis model in rats.
MATERIAL AND METHODS: Periodontitis was induced in seventy-six male Wistar rats using ligature around the lower right first molars. The animals were then treated with parathyroid hormone (1-34) (T-group) or vehicle (C-group), three times a week for 15 d (C15, T15) or 30 d (C30, T30). At each experimental time-point, the 19 rats were killed in each group and the gingival tissue around the first lower molar was removed and prepared for the following analyses: mRNA expression of interleukin-1 beta, interleukin-6, matrix metalloproteinase (MMP)-2 and MMP-9, and gelatinolytic activity of MMP-2 and MMP-9. Hemimandibles were decalcified, and serial sections were processed and analyzed for interleukin-6 immohistochemistry. Samples were also histochemically stained by tartrate-resistant acid phosphatase (TRAP) to evaluate the number of osteoclasts present.
RESULTS: Parathyroid hormone-treated samples showed decreased of levels of mRNA for interleukin-6 in the T30 group (p < 0.01) and of MMP-2 in the T15 and T30 groups (p < 0.05). Zymography assays demonstrated that treatment with parathyroid hormone led to a decrease in MMP-9 activity (p < 0.01). TRAP staining of alveolar bone revealed that osteoclasts were present in higher numbers (p < 0.05) in the groups not treated with parathyroid hormone.
CONCLUSION: These data suggest that intermittent administration of parathyroid hormone can down-regulate the expression of biomarkers responsible for connective tissue breakdown and bone resorption, and potentially affect alveolar bone resorption activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453852     DOI: 10.1111/j.1600-0765.2008.01186.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  5 in total

1.  Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.

Authors:  Dominik Kraus; Andreas Jäger; Nuersailike Abuduwali; James Deschner; Stefan Lossdörfer
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

2.  Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis.

Authors:  Luciana S Branco-de-Almeida; Gilson C Franco; Myrella L Castro; Juliana G Dos Santos; Ana Lia Anbinder; Sheila C Cortelli; Mikihito Kajiya; Toshihisa Kawai; Pedro L Rosalen
Journal:  J Periodontol       Date:  2011-10-03       Impact factor: 6.993

3.  Porphyromonas gingivalis LPS stimulation downregulates DNMT1, DNMT3a, and JMJD3 gene expression levels in human HaCaT keratinocytes.

Authors:  Gláucia de Camargo Pereira; Gustavo Narvaes Guimarães; Aline Cristiane Planello; Mauro Pedrine Santamaria; Ana Paula de Souza; Sergio Roberto Line; Marcelo Rocha Marques
Journal:  Clin Oral Investig       Date:  2012-08-09       Impact factor: 3.573

4.  Simulation Study of Radio Frequency Safety and the Optimal Size of a Single-Channel Surface Radio Frequency Coil for Mice at 9.4 T Magnetic Resonance Imaging.

Authors:  Jeung-Hoon Seo; Yeunchul Ryu; Jun-Young Chung
Journal:  Sensors (Basel)       Date:  2022-06-03       Impact factor: 3.847

Review 5.  Ethical guidelines, animal profile, various animal models used in periodontal research with alternatives and future perspectives.

Authors:  Mohan Kumar Pasupuleti; Subramanya Shetty Molahally; Supraja Salwaji
Journal:  J Indian Soc Periodontol       Date:  2016 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.